Trial Profile
Phase 2 study of SNS-301 in multiple solid tumor indications and hematological malignancies
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 08 Apr 2019
Price :
$35
*
At a glance
- Drugs SNS 301 (Primary)
- Indications Haematological malignancies; Solid tumours
- Focus Therapeutic Use
- 01 Apr 2019 According to Sensei Biotherapeutics media release, company plnas to start this trial in mid-2019.
- 26 Oct 2018 New trial record
- 19 Oct 2018 According to Sensei Biotherapeutics media release,study is expected to start in early 2019.